Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Circulation ; 102(19 Suppl 3): III123-9, 2000 Nov 07.
Article in English | MEDLINE | ID: mdl-11082374

ABSTRACT

BACKGROUND: Controversy regarding the timing for the repair of tetralogy of Fallot centers around initial palliation versus primary repair for the symptomatic neonate/young infant and the optimal age for repair of the asymptomatic child. We changed our approach from one of initial palliation in the infant to one of primary repair around the age of 6 months, or earlier if clinically indicated. We examined the effects of this change in protocol and age on outcomes. METHODS AND RESULTS: The records of 227 consecutive children who had repair of isolated tetralogy of Fallot from January 1993 to June 1998 were reviewed. The median age of repair by year fell from 17 to 8 months (P:<0.01). The presence of a palliative shunt at the time of repair decreased from 38% to 0% (P:<0.01). Mortality (6 deaths, 2. 6%) improved with time (P:=0.02), with no mortality since the change in protocol (late 1995/early 1996). Multivariate analysis for physiological outcomes of time to lactate clearance, ventilation hours, and length of stay, but not death, demonstrated that an age <3 months was independently associated with prolongation of times (P:<0.03). Each of the deaths occurred with primary repair at an age >12 months. The best survival and physiological outcomes were achieved with primary repair in children aged 3 to 11 months. CONCLUSIONS: On the basis of mortality and physiological outcomes, the optimal age for elective repair of tetralogy of Fallot is 3 to 11 months of age.


Subject(s)
Tetralogy of Fallot/surgery , Age Distribution , Age Factors , Blood Pressure , Canada , Cardiac Surgical Procedures/methods , Cardiac Surgical Procedures/mortality , Cardiac Surgical Procedures/statistics & numerical data , Child , Child, Preschool , Cohort Studies , Female , Humans , Infant , Infant, Newborn , Lactic Acid/blood , Length of Stay/statistics & numerical data , Male , Multivariate Analysis , Palliative Care/statistics & numerical data , Reoperation/statistics & numerical data , Survival Rate , Tetralogy of Fallot/blood , Tetralogy of Fallot/mortality , Treatment Outcome
2.
Biomed Mater Eng ; 4(3): 193-8, 1994.
Article in English | MEDLINE | ID: mdl-7950868

ABSTRACT

Carbon fiber reinforced polyetheretherketone (C/PEEK) composite materials are being investigated as an alternative to metal in the femoral component of a total hip arthroplasty. Wear is among the issues that must be addressed before introducing a new orthopaedic implant material. This study examines the generation of wear debris when zirconia femoral heads are mechanically attached to C/PEEK trunnions and loaded under simulated physiological conditions. Mechanical testing was performed on a trunnion/head assembly loaded from 445 to 4450N at an angle of 39 degrees to the long axis of the trunnion. The trunnions were tested at a frequency of 20 Hz for 10 million cycles. After completion of the fatigue test, solution from the test assembly was characterized by laser scattering and by SEM image analysis to determine the size, shape, total number, and identify of the particles. In addition, the peak load to pull the head from the trunnion was measured. The total number of particles generated during the test was in the range of 10(5) as indicated by both laser scattering and (SEM) image analysis. Both carbon fiber and PEEK particles were found in an average proportion of about 1:13, respectively. The carbon fiber particle size average was 153 microns and the PEEK particle size average was 2.2 microns. The zirconia heads remained well attached to the C/PEEK trunnions as indicated by a mean peak distraction force of 1942 +/- 116N.


Subject(s)
Biocompatible Materials , Composite Resins/chemistry , Hip Prosthesis , Ketones , Materials Testing , Polyethylene Glycols , Benzophenones , Biomechanical Phenomena , Carbon , Carbon Fiber , Ceramics , Humans , Ketones/chemistry , Microscopy, Electron, Scanning , Particle Size , Polyethylene Glycols/chemistry , Polymers , Prosthesis Design , Prosthesis Failure
3.
Eur J Biochem ; 196(2): 271-80, 1991 Mar 14.
Article in English | MEDLINE | ID: mdl-1848814

ABSTRACT

Four spin-labeled inhibitors of dihydrofolate reductase (DHFR) have been synthesized, each of which has the 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) reporting group at a different distance from the 2,4-diaminopyrimidine moiety by which the inhibitors are anchored and oriented in the active site. Inhibitors in which the TEMPO group is attached by a short side chain are weakly bound to DHFR from bacteria (Streptococcus faecium and Lactobacillus casei), to the bovine enzyme and to recombinant human DHFR. However, binding is sufficiently tight, especially in the ternary complexes with NADPH, for recording of the EPR spectra of the bound ligands. The spectra indicate that when these inhibitors are bound to the enzyme the TEMPO group is highly immobilized with correlation time, tau c, 4-20ns. Inhibitors that have the reporter group attached to the glutamate moiety of methotrexate bind to all four DHFRs more tightly than the inhibitors with shorter side chains by factors of up to 10(6). However, in most complexes formed by the inhibitors with longer side chains immobilization of the TEMPO group is slight (tau c 0.2-4 ns). These results are in general agreement with predictions from X-ray crystallographic results including thermal factors but there are some unanticipated differences between some results for bacterial and eukaryotic enzymes. Three of the splin-labeled inhibitors would provide good probes for distance measurements in and around the active site of mammalian DHFR.


Subject(s)
Cyclic N-Oxides/metabolism , Folic Acid Antagonists , Tetrahydrofolate Dehydrogenase/metabolism , Animals , Cattle , Cyclic N-Oxides/chemical synthesis , Electron Spin Resonance Spectroscopy , Humans , Lacticaseibacillus casei/enzymology , Ligands , Liver/enzymology , NADP/metabolism , Recombinant Proteins , Spin Labels , Streptococcus/enzymology , Structure-Activity Relationship
4.
Biochemistry ; 29(19): 4554-60, 1990 May 15.
Article in English | MEDLINE | ID: mdl-2372539

ABSTRACT

The dissociation constants (pKa) for the pteridine ring system of dihydrofolate (H2folate) have been redetermined, and those for dihydrobiopterin (H2biopterin) have been determined. Determination of the pKa for N5 of H2folate is complicated by the low solubility and instability of H2folate at pH 2-4, and other complicating factors. The initial rate of absorbance change due to degradation is a maximum at pH 2.5, and the products depend on the oxygen concentration: under aerobic conditions, (p-aminobenzoyl)glutamic acid and 7,8-dihydropterin-6-carboxaldehyde are major products. H2Biopterin is much more soluble and more stable at low pH. For protonation of N5, the pKa is 2.56 +/- 0.01 for H2biopterin and 2.59 +/- 0.03 for H2folic acid. Spectrophotometric determination of the pKa for the N3-O4 amide group of H2folate is subject to serious errors when a wavelength between 220 and 235 nm is used. These errors arise from the pH-dependent absorbance of mercaptoethanol often present in the preparation. The amide group has a pKa of 10.41 +/- 0.04 in H2biopterin and 10.85 +/- 0.04 in H2folate. The redetermined value for the pKa of N5 of H2folate has implications for mechanistic models for dihydrofolate reductase, and revised kinetic constants have been calculated for one model.


Subject(s)
Biopterins/analogs & derivatives , Folic Acid/analogs & derivatives , Tetrahydrofolate Dehydrogenase/metabolism , Biopterins/metabolism , Folic Acid/metabolism , Hydrogen-Ion Concentration , Kinetics , Mercaptoethanol , Models, Chemical , Osmolar Concentration , Solubility , Spectrophotometry, Ultraviolet
SELECTION OF CITATIONS
SEARCH DETAIL
...